跳至主要内容
临床试验/JPRN-UMIN000000991
JPRN-UMIN000000991已完成未知

Prevention of incident fracture of Osteoporosis in Japan(Multi-center Randomized Trial with Risedronate and VitaminK2) - Japanese Osteoporosis Intervention Trial -03 (JOINT-03)

Japan Osteoporosis Society/A-TOP consortium0 个研究点目标入组 1,983 人开始时间: 2008年2月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,983

研究概览

简要总结

Concurrent treatment with vitamin K2 and risedronate was not efficacious compared with monotherapy with risedronate in terms of fracture prevention.

研究设计

研究类型
Interventional

入排标准

年龄范围
65years-old 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1.Using warfarin 2.Secondary osteoporosis and low bone mass disease except osteoporosis 3.Having contraindication in using drugs 4.Hypothyroidism and hyperparathyroidism 5.Disfunction of communication of the intention 6.Prevalent vertebral fracture>=6 7.Deformation of vertebra 8.Abnormal heart function,abnormal hepatic function,abnormal kidney function 9.Taken bisphosphonate within previous 6 months

研究者

发起方
Japan Osteoporosis Society/A-TOP consortium

相似试验